Erica van Oort

Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus

D. A. Horbach, Erica van Oort, Richard C. J. M. Donders et al. · Thrombosis and Haemostasis · 1996 · 255 citations

Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect

Alienke J. Monsuur, Paul I. W. de Bakker, Behrooz Z. Alizadeh et al. · Nature Genetics · 2005 · 243 citations

Myosin Ixb Variant, Autoimmune Disease, Pathogenesis +8

The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity--discrimination between functional and non-functional anti-prothrombin-antibodies.

D. A. Horbach, Erica van Oort, R. H. W. M. Derksen et al. · PubMed · 1998 · 72 citations

Immunology, Pathology, Immunotherapy +19

The Contribution of Anti-prothrombin-antibodies to Lupus Anticoagulant Activity

Erica van Oort, Ronald H. W. M. Derksen, Philip de Groot et al. · Thrombosis and Haemostasis · 1998 · 70 citations

Immunohematology, Immunodeficiencies, Immunology +19

Beta2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis.

D. A. Horbach, Erica van Oort, Ton Lisman et al. · PubMed · 1999 · 53 citations

Proteinlipid Interaction, Protein Secretion, Glycobiology +19